<DOC>
	<DOCNO>NCT00727090</DOCNO>
	<brief_summary>Conivaptan ( Vaprisol ) FDA-Approved treatment low serum sodium ( hyponatremia ) , data patient neurologic disease . Very low serum sodium patient brain injury life-threatening associate cerebral edema ( swell brain tissue ) . This important patient brain hemorrhage , brain tumor , stroke ( cerebral infarction ) . This pilot study test hypothesis conivaptan ( Vaprisol ) lead great increase sodium usual care . Patients randomly assign usual care lower FDA-approved dose conivaptan ( Vaprisol ) . We track use intervention , use hypertonic saline ( concentrated salt solution ) , diuretic salt tablet . A blinded co-investigator record neurologic examination result ( NIH Stroke Scale Glasgow Coma Scale ) .</brief_summary>
	<brief_title>Use Conivaptan ( Vaprisol ) Hyponatremic Neuro-ICU Patients</brief_title>
	<detailed_description />
	<mesh_term>Hyponatremia</mesh_term>
	<mesh_term>Conivaptan</mesh_term>
	<criteria>severe hyponatremia ( Na &lt; 130 mmol/L ) symptomatic hyponatremia Na &lt; 135 mmol/L least six hour Glasgow Coma Scale &lt; 15 Enrollment NMH highrisk spine protocol . These patient receive large amount fluid , rapid change electrolyte , typically correct 48 hour Expected death cause Known sensitivity allergy conivaptan Renal failure ( baseline creatinine &gt; 1.5 mg/dL ) Clinical diagnosis hypovolemia , central venous pressure ( CVP ) &lt; 5 mm Hg central venous catheter place Concomitant use potent inhibitor cytochrome P450 isoenzyme 3A4 ( e.g. , ketoconazole , itraconazole , clarithromycin , ritonavir , indinavir ) . These agent commonly use NeuroICU Clinical diagnosis liver failure insufficiency Pregnancy ( must exclude entry ) Lack informed consent patient legally authorize representative ( LAR ) Use intraarterial vasodilator ( e.g . verapamil , nicardipine ) within 24 hour ( e.g . vasospasm SAH ) Concern NeuroICU pharmacist drugdrug interaction would meaningfully impact care ( NeuroICU pharmacist review medication regimen recruitment ) Patients diagnosis diabetes insipidus treat vasopressin , since patient already treat abnormal free water balance Patients congestive heart failure , since approve use drug ( patient typically care NeuroICU ) Age &lt; 18 year ( patient care NMH ) Inclusion decline attend physician consulting study nephrologist</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>